Published in Virus Weekly, October 2nd, 2007
The significance of this data lies in the fact that CEL-1000 appears to be able to mount a faster immune response, something...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly